Nuvation Bio Inc.

AI Score

XX

Unlock

1.77
-0.05 (-2.75%)
At close: Mar 31, 2025, 3:59 PM

Nuvation Bio Statistics

Share Statistics

Nuvation Bio has 337.68M shares outstanding. The number of shares has increased by 54.36% in one year.

Shares Outstanding 337.68M
Shares Change (YoY) 54.36%
Shares Change (QoQ) 0.83%
Owned by Institutions (%) 72.27%
Shares Floating 226.82M
Failed to Deliver (FTD) Shares 86
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 22.05M, so 6.55% of the outstanding shares have been sold short.

Short Interest 22.05M
Short % of Shares Out 6.55%
Short % of Float 9.63%
Short Ratio (days to cover) 7.37

Valuation Ratios

The PE ratio is -1.26 and the forward PE ratio is -4.8. Nuvation Bio's PEG ratio is 0.

PE Ratio -1.26
Forward PE -4.8
PS Ratio 90.81
Forward PS 1.6
PB Ratio 1.54
P/FCF Ratio -5.48
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Nuvation Bio Inc. has an Enterprise Value (EV) of 291.87M.

EV / Earnings -0.51
EV / Sales 37.07
EV / EBITDA -0.51
EV / EBIT -0.49
EV / FCF -2.24

Financial Position

The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.02.

Current Ratio 9.04
Quick Ratio 9.04
Debt / Equity 0.02
Total Debt / Capitalization 1.89
Cash Flow / Debt -14.63
Interest Coverage -1737.91

Financial Efficiency

Return on equity (ROE) is -1.22% and return on capital (ROIC) is -125.37%.

Return on Equity (ROE) -1.22%
Return on Assets (ROA) -1.05%
Return on Capital (ROIC) -125.37%
Revenue Per Employee $35,786.36
Profits Per Employee $-2,581,540.91
Employee Count 220
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -50.27% in the last 52 weeks. The beta is 1.47, so Nuvation Bio's price volatility has been higher than the market average.

Beta 1.47
52-Week Price Change -50.27%
50-Day Moving Average 2.19
200-Day Moving Average 2.67
Relative Strength Index (RSI) 37.1
Average Volume (20 Days) 2.56M

Income Statement

In the last 12 months, Nuvation Bio had revenue of 7.87M and earned -567.94M in profits. Earnings per share was -2.11.

Revenue 7.87M
Gross Profit 795K
Operating Income -592.63M
Net Income -567.94M
EBITDA -566.91M
EBIT -592.63M
Earnings Per Share (EPS) -2.11
Full Income Statement

Balance Sheet

The company has 35.72M in cash and 8.91M in debt, giving a net cash position of 26.81M.

Cash & Cash Equivalents 35.72M
Total Debt 8.91M
Net Cash 26.81M
Retained Earnings -910.74M
Total Assets 540.63M
Working Capital 468.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -130.41M and capital expenditures -162K, giving a free cash flow of -130.57M.

Operating Cash Flow -130.41M
Capital Expenditures -162K
Free Cash Flow -130.57M
FCF Per Share -0.49
Full Cash Flow Statement

Margins

Gross margin is 10.1%, with operating and profit margins of -7.53K% and -7.21K%.

Gross Margin 10.1%
Operating Margin -7.53K%
Pretax Margin -7.21K%
Profit Margin -7.21K%
EBITDA Margin -7.2K%
EBIT Margin -7.53K%
FCF Margin -1.66K%

Dividends & Yields

NUVB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -116.57%
FCF Yield -21.3%
Dividend Details

Analyst Forecast

The average price target for NUVB is $10, which is 452.5% higher than the current price. The consensus rating is "Buy".

Price Target $10
Price Target Difference 452.5%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Scores

Altman Z-Score 0.13
Piotroski F-Score 2